Metraipolis › archive › dc_83e22ca6be82

Healthcare reform in the United States and China: pharmaceutical market implications — Europe PMC PMID:25097759

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/25097759
DOI
10.1186/2052-3211-7-9
License (as archived)
solo-consultazione
Archived
2026-10-08T07:41:50.115Z
SHA-256 of the archived text
80b21fe670e0fa08737eaf50e8db11c7cc2124f66523a9246d58fcaa78aa7512
Stable URL of this page
https://metraipolis.com/documento/dc_83e22ca6be82

How to cite

Healthcare reform in the United States and China: pharmaceutical market implications — Europe PMC PMID:25097759 — Europe PMC (en), https://europepmc.org/article/MED/25097759 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_83e22ca6be82 (Metraipolis archive dc_83e22ca6be82, sha256 80b21fe670e0fa08737eaf50e8db11c7cc2124f66523a9246d58fcaa78aa7512)
BibTeX
@misc{dc83e22ca6be82,
  title = {Healthcare reform in the United States and China: pharmaceutical market implications — Europe PMC PMID:25097759},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/25097759},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_83e22ca6be82; sha256 80b21fe670e0fa08737eaf50e8db11c7cc2124f66523a9246d58fcaa78aa7512},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/25097759. Agents can read the archived copy with the MCP tool read_document.